Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PCSK6 and Survival in Idiopathic Pulmonary Fibrosis
Justin M. Oldham, Richard J. Allen, José M. Lorenzo-Salazar, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 207, Iss. 11, pp. 1515-1524
Open Access | Times Cited: 23

Showing 23 citing articles:

Precision medicine advances in idiopathic pulmonary fibrosis
Τheodoros Karampitsakos, Brenda Juan-Guardela, Argyris Tzouvelekis, et al.
EBioMedicine (2023) Vol. 95, pp. 104766-104766
Open Access | Times Cited: 66
Genetics of chronic respiratory disease
Ian Sayers, Catherine John, Jing Chen, et al.
Nature Reviews Genetics (2024) Vol. 25, Iss. 8, pp. 534-547
Closed Access | Times Cited: 10
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine
Ayodeji Adegunsoye, Jonathan A. Kropski, Jürgen Behr, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 4, pp. 401-423
Closed Access | Times Cited: 9
Interplay between genetics and epigenetics in lung fibrosis
Arvind G Valand, Poojitha Rajasekar, Louise V. Wain, et al.
The International Journal of Biochemistry & Cell Biology (2025), pp. 106739-106739
Open Access | Times Cited: 1
Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine
Aitana Alonso-González, Eva Tosco-Herrera, María Molina‐Molina, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 13
Imperfect wound healing sets the stage for chronic diseases
Paul Martin, Carlos Pardo-Pastor, Gisli Jenkins, et al.
Science (2024) Vol. 386, Iss. 6726
Closed Access | Times Cited: 4
Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis
Zhe Chen, Mimi L.K. Tang, Nan Wang, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Recent advances in the genetics of idiopathic pulmonary fibrosis
Paolo Spagnolo, Joyce Lee
Current Opinion in Pulmonary Medicine (2023) Vol. 29, Iss. 5, pp. 399-405
Open Access | Times Cited: 9
Reassessing the association of MUC5B with survival in idiopathic pulmonary fibrosis
Siyang Cai, Richard J. Allen, Louise V. Wain, et al.
Annals of Human Genetics (2023) Vol. 87, Iss. 5, pp. 248-253
Open Access | Times Cited: 7
Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosis
Beatriz Guillén‐Guío, Megan L. Paynton, Richard J. Allen, et al.
ERJ Open Research (2023) Vol. 10, Iss. 1, pp. 00553-2023
Open Access | Times Cited: 4
A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosis
Janelle Vu Pugashetti, John S. Kim, M.P. Combs, et al.
The Journal of Heart and Lung Transplantation (2024) Vol. 43, Iss. 7, pp. 1174-1182
Closed Access | Times Cited: 1
Genetic burden of dysregulated cytoskeletal organisation in the pathogenesis of pulmonary fibrosis
Dapeng Wang, Yujie Ni, Bin Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
“Alveolar stem cell exhaustion, fibrosis and bronchiolar proliferation” related entities. A narrative review
M. Chilosi, Sara Piciucchi, Claudia Ravaglia, et al.
Pulmonology (2024)
Open Access | Times Cited: 1
Contemporary Concise Review 2023: Interstitial lung disease
Yuben Moodley
Respirology (2024) Vol. 29, Iss. 12, pp. 1095-1100
Open Access | Times Cited: 1
Contemporary Concise Review 2022: Interstitial lung disease
D. Smith, Gisli Jenkins
Respirology (2023) Vol. 28, Iss. 7, pp. 627-635
Open Access | Times Cited: 3
Transcriptome-Wide Association Study of Idiopathic Pulmonary Fibrosis Survival Identifies PTPN9 and SNRPB2
Xiaowei Hu, John S. Kim, Aabida Saferali, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 5, pp. 683-686
Closed Access
Biomarker-defined endotypes of pulmonary fibrosis
A. Scott McCall, Jonathan A. Kropski
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 9, pp. 657-659
Closed Access
Rare variants and survival of patients with idiopathic pulmonary fibrosis
Aitana Alonso-González, David Jáspez, José M. Lorenzo-Salazar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Tobacco use: a smoking gun for IPF?
Ian P. Hall
Thorax (2023) Vol. 79, Iss. 2, pp. 104-105
Closed Access | Times Cited: 1
Proprotein Convertase Subtilisin/Kexin Type 6: A Risk Factor for Survival in Pulmonary Fibrosis?
Ivana V. Yang
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 207, Iss. 11, pp. 1421-1422
Open Access
Reply to Spek and Duitman
Justin M. Oldham, Richard J. Allen, José M. Lorenzo-Salazar, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 207, Iss. 12, pp. 1644-1645
Open Access
PCSK6: The Endogenous PAR-1 Agonist Driving Pulmonary Fibrosis?
C. Arnold Spek, JanWillem Duitman
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 207, Iss. 12, pp. 1643-1644
Open Access
Mendelian randomization analysis suggests no causal influence of gastroesophageal reflux disease on the susceptibility and prognosis of idiopathic pulmonary fibrosis
Di Sun, Qiao Ye
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access
Page 1

Scroll to top